High neutrophil-lymphocyte ratio indicates a worse response to ursodeoxycholic acid in primary biliary cholangitis: a retrospective cohort study
Abstract Background Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by inflammation of the interlobular bile ducts. Ursodeoxycholic acid (UDCA) is the only FDA approved first-line therapy for PBC, but up to 40% of patients with PBC have an incomplete response t...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2023-11-01
|
| Serie: | BMC Gastroenterology |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1186/s12876-023-03031-8 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|